MHUAF · available-data snapshot
Meihua International Medical Technologies Co., Ltd. (MHUAF): Available-Data Snapshot
TickerWorth does not publish a DCF fair value for Meihua International Medical Technologies Co., Ltd. (MHUAF); the reason is set out below. What its filings and market data do show is below. The snapshot also sets out its trading multiples against 5 peers. Snapshot as of Oct 19, 2026.
Model by Miraaj Patel · generated from public market data · Updated Oct 19, 2026 · How these pages are made
Why is there no fair value for MHUAF?
We do not publish a fair value for Meihua International Medical Technologies Co., Ltd.. What we can say from its filings and market data is below.
What is MHUAF's TickerWorth Score?
A weaker business than most companies
Compared with Healthcare companies in US
Its strongest point: looks cheap on the numbers. Its weakest: growth is slow or negative.
- Value · 75 of 100
Cheaper than 75% of Healthcare companies in US
- Price vs worth · — of 100
- Quality · 50 of 100
More profitable than 50% of Healthcare companies in US
- Financial health · 56 of 100
Financially stronger than 56% of Healthcare companies in US
- Growth · 8 of 100
Growing faster than 8% of Healthcare companies in US
- Momentum · 5 of 100
Outperformed 5% of Healthcare companies in US over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
- Price
- $6.40
- Market cap
- $5,
475, 808 - 52-week high
- $32.90
- 52-week low
- $2.05
- Currency
- USD
- Exchange
- OTC Markets OTCQB
Snapshot of Oct 19, 2026, quote time not published · Prices are delayed.
What we can say
We don't publish a discounted-cash-flow fair value for Meihua International Medical Technologies Co., Ltd. (MHUAF) because the free data sources we rely on don't expose the multi-year financials a DCF needs — common for small or thinly-covered listings. Rather than invent numbers, this page shows an honest snapshot of what the public data does support: the current price and size, any relative valuation multiples that exist, a book-value view, and a price-based read. Treat it as a descriptive starting point, not a valuation and not investment advice.
Read the full reasoning
On the numbers we do have, MHUAF trades at a recent price of $6.40, a market capitalisation of about $5,475,808, sitting 14% of the way up its 52-week range ($2.05–$32.90), on the OTC Markets OTCQB.
The standard alternative to a DCF is relative valuation — comparing MHUAF's trading multiples against a sector benchmark. Here that gives P/E of 0.4× (cheaper than the peer median of 41.9×); P/B of 0.0× (cheaper than the peer median of 7.8×); P/S of 0.1× (cheaper than the peer median of 6.2×). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.
The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. MHUAF shows a price-to-book (P/B) of 0.02 and book value of $271.61 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.
Finally, a price-based read — explicitly not a valuation. MHUAF is in a down-trend (price below both its 50- and 200-day averages), trading -80.5% from its 52-week high. Over the past year the stock is -80.0%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.
MHUAF vs peers
Sector benchmark (bellwethers, not direct competitors).
| Multiple | MHUAF | Peer median | Read |
|---|---|---|---|
| P/E | 0.4× | 41.9× | cheaper than |
| P/B | 0.0× | 7.8× | cheaper than |
| P/S | 0.1× | 6.2× | cheaper than |
What does Meihua International Medical Technologies Co., Ltd. do?
What does it do?
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China, Europe, North America, South America, Asia, Africa, and Oceania. It operates in the Medical Instruments & Supplies industry (Healthcare sector), headquartered in China. The company employs roughly 486 people.
How does it make money?
The business turns $62M in annual revenue into profit. Out of every $100 of sales, about $21 is left as operating profit (operating margin of 21.2%), after a 31% gross margin on the products/services it sells. After all costs, taxes and interest, 11.0% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks mixed: carries heavy debt (4.8× equity), comfortably covers its short-term bills (8.4× current ratio), and is currently profitable.
MHUAF insider trading
We have no recent SEC Form 4 insider filings on file for Meihua International Medical Technologies Co., Ltd.. Form 4 covers US-listed companies only.
Companies we do put a number on
Not investment advice. TickerWorth Score is a model output.
A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public market data that can be wrong, stale or incomplete.